Orthostatic Hypotension clinical trials

Explore recruiting orthostatic hypotension clinical trials.

Recruiting orthostatic hypotension studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Orthostatic Hypotension trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Evaluation of efficacy and tolerance of fludrocortisone (Flucortac) in the treatment of neurogenic orthostatic hypotension

France

Therapeutic use (Phase IV) EU CTIS Study details

A Phase 3, Multi-center, Randomized Withdrawal and Long-Term Extension Study of Ampreloxetine for the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Participants with Multiple System Atrophy

Denmark, Spain, Austria, France, Germany, Italy +5 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Multicentre, Randomised, Double-blind, Placebo-controlled, Phase IIb Study to Evaluate the Safety of Zibotentan/Dapagliflozin in Combination Compared to Zibotentan Monotherapy as well as Zibotentan/Dapagliflozin and Zibotentan Monotherapy Compared to Placebo in Participants with Cirrhosis

Belgium, Slovakia, Czechia, Germany, Italy, Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

Swedish Cardiac And Renal Failure study-1 (SCARF-1): An open-label pilot trial to evaluate the feasibility, safety and efficacy of eplerenone in patients with heart failure with reduced ejection fraction and severe chronic kidney disease.

Sweden

Therapeutic exploratory (Phase II) EU CTIS Study details

Double-blind, Randomized, Placebo-controlled Phase 3 study Evaluating Efficacy and Safety of IgPro20 (subcutaneous immunoglobulin, HIZENTRA®) in post-COVID-19 Postural Orthostatic Tachycardia Syndrome (POTS)

Germany, Italy, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

THINK - intensification of blood pressure lowering Therapeutics based on diuretics versus usual management for uncontrolled Hypertension IN patients with moderate to severe chronic Kidney disease: an open label, cluster randomized controlled, phase 3 trial

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Orthostatic Hypotension trials by city

Orthostatic Hypotension in Toronto Orthostatic Hypotension in Vancouver Orthostatic Hypotension in Montreal Orthostatic Hypotension in Calgary Orthostatic Hypotension in Edmonton Orthostatic Hypotension in Ottawa Orthostatic Hypotension in Winnipeg Orthostatic Hypotension in Quebec City Orthostatic Hypotension in Hamilton Orthostatic Hypotension in Kitchener Orthostatic Hypotension in London Orthostatic Hypotension in Halifax Orthostatic Hypotension in New York Orthostatic Hypotension in Los Angeles Orthostatic Hypotension in Chicago Orthostatic Hypotension in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease